Diaz, J.C., Vallejo, S. & Cañas, C.A. Rheumatol Int (2012) 32: 3315. doi:10.1007/s00296-011-2137-y
We report three patients with rheumatoid arthritis (RA) who were treated with anti-TNF-α agents and who developed drug-induced lupus (DIL). Two of them received etanercept and the remainder adalimumab. We also present the favorable response observed with the withdrawal of the anti-TNF-alpha agents and the introduction of rituximab. Through this intervention, we observed a very good control of the activity of both DIL and RA without additional adverse reactions.